Regulatory T cells (Tregs) are crucial in inducing and maintaining tolerance. This unique
capacity of Tregs, in combination with proof-of-principle in preclinical studies, highlights the …

Organ transplantation is the optimal treatment for terminal and irreversible organ failure.
Achieving transplantation tolerance has long been the ultimate goal in the field of …

The concept of regulatory T cell (Treg)-based immunotherapy has enormous potential for
facilitating tolerance in autoimmunity and transplantation. Clinical translation of Treg cell …

Regulatory T cell (Treg) therapy has shown promise in early clinical trials for treating graft-
versus-host disease, transplant rejection and autoimmune disorders. A challenge has been …

Regulatory T cells (Tregs) are critical mediators of immune homeostasis and hold significant
promise in the quest for transplantation tolerance. Progress has now reached a critical …

Regulatory T cells (Tregs) are an important subset of adaptive immune cells and control
immune reactions for maintaining homeostasis. Tregs are generated upon their encounter …

Regulatory T cells (Tregs) are a unique subset of lymphocytes that play a vital role in
regulating the immune system by suppressing unwanted immune responses and thus …

Immune-suppressive cellular immunotherapy requires large numbers of antigen-specific
regulatory T cells (Treg cells), lymphocytes that suppress certain immune responses …

Regulatory T cells (Tregs) play an important role in immunoregulation and have been shown
in animal models to promote transplantation tolerance and curb autoimmunity following their …

Engineered regulatory T (Treg) cells have emerged as precision therapeutics aimed at
inducing immune tolerance while reducing the risks associated with generalized …